Exploring the Potential for Therapeutic Lineage Reprogramming of Diabetes

Project Information

TheLiRep

Grant agreement ID: 641036

DOI

10.3030/641036

Project closed

EC signature date 11 March 2015

Start date 1 May 2015

End date 31 October 2016

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 150 000,00

EU contribution

€ 150 000,00

Coordinated by

MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Intellectual Property Rights

Patent (2)

TGIF2-INDUCED REPROGRAMMING OF HEPATIC CELLS TO PANCREATICPROGENITOR CELLS AND MEDICAL USES THEREOF

Application/Publication number: USPTO Application Nr. 14/800,880
Date: 2015-07-07
Applicant(s): MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)

Tgif2-induced reprogramming of hepatic cells to pancreatic progenitor cells and medical uses thereof

Application/Publication number: EP 14177287
Date: 2014-07-16
Applicant(s): MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)